Reason reports back from Rejuvenation Startup Summit 2024
Fight Aging! - 13-May-2024A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
SENISCA
University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing
SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics).
Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells.
At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new generation of interventions, to turn back the ageing clock in old cells and to target the diseases and aesthetic signs of ageing. SENISCA interventions are small molecule or oligonucleotide-based.
Senisca Executive Team
- Sarah Cole, CEO
- Lorna Harries - CSO
- Ben Lee - CTO
- Kirsty Semple - COO
- Tim Schmidt - CDO
Senisca Advisory Board
- David Chiswell - Chairman
- Allan Weiner - Non-Executive Director
- Scott Beattie - Non-Executive Director
- Richard Haycock - Non-Executive Director
- Steve Wilton - Scientific Advisor
Visit website: https://www.senisca.com/
See also
University of Exeter
UK university and member of the Russell Group of leading research-intensive UK universities
Details last updated 05-Aug-2020
SENISCA News
SENISCA secures 3.7 million euros to fight aging with RNA-based therapies
Longevity Technology - 18-Mar-2024Developing senotherapeutics to target cellular senescence and treat age-related diseases
UK biotech races US giants for longevity breakthrough
The Guardian - 05-Nov-2023British researchers and startups vie to outpace tech billionaires in the fight against ageing
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Exeter's company SENISCA raises £2 million to treat age-related chronic diseases
University of Exeter - 09-Jun-2022Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests
Display all news
Mentioned in this Resource
Topics mentioned on this page:
Senescent Cells
